Article
Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model.
Blood - 23 Jul 2026
Rajamanickam Shivakumar, Trescott Samantha, Mak Samantha, Warden Anna S, Wilpitz Amanda M, Xia Bing, Nguyen Celina, Ding Hilda, Picarsic Jennifer, Glass Christopher K, Allen Carl E, Coufal Nicole G
Abstract excerpt
ABSTRACT: Innate immunity is increasingly recognized as a driver of neurodegeneration, although pathogenic mechanisms are incompletely understood. Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic disorder caused by activating somatic mutations in MAPK pathway genes, most commonly BRAFV600E, in myeloid precursors. A subset of patients with LCH develop progressive neurodegeneration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
